Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Decoding the enigma of antiviral crisis: Does one target molecule regulate all?

Identifieur interne : 000941 ( PubMed/Corpus ); précédent : 000940; suivant : 000942

Decoding the enigma of antiviral crisis: Does one target molecule regulate all?

Auteurs : Abdullah Mahmud-Al-Rafat ; Apurba Majumder ; K M Taufiqur Rahman ; A M Mahedi Hasan ; K M Didarul Islam ; Andrew W. Taylor-Robinson ; Md Morsaline Billah

Source :

RBID : pubmed:30616034

Abstract

Disease fatality associated with Ebola, SARS-CoV and dengue infections in humans is attributed to a cytokine storm that is triggered by excessive pro-inflammatory responses. Interleukin (IL)-6 acts as a mediator between pro- and anti-inflammatory reactivity by initiating trans- and classical-signaling, respectively. Hence, IL-6 is assumed to provide a target for a broad range of antiviral agents. Available immunosuppressive antivirals are directed to control an often exaggerated pro-inflammatory response that gives rise to complex clinical conditions such as lymphocytopenia. It is known that IL-6, via its soluble receptor (sIL-6R), initiates a pro-inflammatory response while an anti-inflammatory response is triggered by the membrane-bound IL-6 receptor (IL-6R). Future antivirals should thus aim to target the mechanism that regulates switching between IL-6 trans- and classical-signaling. In this review, we propose that the tumour necrosis factor-α converting enzyme ADAM-17 could be the master molecule involved in regulating IL-6 class switching and through this in controlling pro- and anti-inflammatory responses to viral antigenic stimuli. Therefore, ADAM-17 should be considered as a potential target molecule for novel antiviral drug discovery that would regulate host reactivity to infection and thereby limit or prevent fatal outcomes.

DOI: 10.1016/j.cyto.2018.12.008
PubMed: 30616034

Links to Exploration step

pubmed:30616034

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Decoding the enigma of antiviral crisis: Does one target molecule regulate all?</title>
<author>
<name sortKey="Mahmud Al Rafat, Abdullah" sort="Mahmud Al Rafat, Abdullah" uniqKey="Mahmud Al Rafat A" first="Abdullah" last="Mahmud-Al-Rafat">Abdullah Mahmud-Al-Rafat</name>
<affiliation>
<nlm:affiliation>Research & Development Division, Incepta Vaccine Ltd., Zirabo, Savar, Dhaka 1341, Bangladesh; Biotechnology and Genetic Engineering Discipline, Khulna University, Khulna 9208, Bangladesh. Electronic address: mahmud0907@gmail.com.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Majumder, Apurba" sort="Majumder, Apurba" uniqKey="Majumder A" first="Apurba" last="Majumder">Apurba Majumder</name>
<affiliation>
<nlm:affiliation>Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover 30625, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Taufiqur Rahman, K M" sort="Taufiqur Rahman, K M" uniqKey="Taufiqur Rahman K" first="K M" last="Taufiqur Rahman">K M Taufiqur Rahman</name>
<affiliation>
<nlm:affiliation>Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, Ontario K1N6N5, Canada. Electronic address: krahm066@uottawa.ca.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mahedi Hasan, A M" sort="Mahedi Hasan, A M" uniqKey="Mahedi Hasan A" first="A M" last="Mahedi Hasan">A M Mahedi Hasan</name>
<affiliation>
<nlm:affiliation>Institute of Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3FF, UK. Electronic address: A.M.M.Hasan@ed.ac.uk.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Didarul Islam, K M" sort="Didarul Islam, K M" uniqKey="Didarul Islam K" first="K M" last="Didarul Islam">K M Didarul Islam</name>
<affiliation>
<nlm:affiliation>Biotechnology and Genetic Engineering Discipline, Khulna University, Khulna 9208, Bangladesh.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Taylor Robinson, Andrew W" sort="Taylor Robinson, Andrew W" uniqKey="Taylor Robinson A" first="Andrew W" last="Taylor-Robinson">Andrew W. Taylor-Robinson</name>
<affiliation>
<nlm:affiliation>School of Health, Medical & Applied Sciences, Central Queensland University, Brisbane, QLD 4000, Australia. Electronic address: a.taylor-robinson@cqu.edu.au.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Billah, Md Morsaline" sort="Billah, Md Morsaline" uniqKey="Billah M" first="Md Morsaline" last="Billah">Md Morsaline Billah</name>
<affiliation>
<nlm:affiliation>Biotechnology and Genetic Engineering Discipline, Khulna University, Khulna 9208, Bangladesh. Electronic address: morsaline@yahoo.com.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:30616034</idno>
<idno type="pmid">30616034</idno>
<idno type="doi">10.1016/j.cyto.2018.12.008</idno>
<idno type="wicri:Area/PubMed/Corpus">000941</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000941</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Decoding the enigma of antiviral crisis: Does one target molecule regulate all?</title>
<author>
<name sortKey="Mahmud Al Rafat, Abdullah" sort="Mahmud Al Rafat, Abdullah" uniqKey="Mahmud Al Rafat A" first="Abdullah" last="Mahmud-Al-Rafat">Abdullah Mahmud-Al-Rafat</name>
<affiliation>
<nlm:affiliation>Research & Development Division, Incepta Vaccine Ltd., Zirabo, Savar, Dhaka 1341, Bangladesh; Biotechnology and Genetic Engineering Discipline, Khulna University, Khulna 9208, Bangladesh. Electronic address: mahmud0907@gmail.com.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Majumder, Apurba" sort="Majumder, Apurba" uniqKey="Majumder A" first="Apurba" last="Majumder">Apurba Majumder</name>
<affiliation>
<nlm:affiliation>Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover 30625, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Taufiqur Rahman, K M" sort="Taufiqur Rahman, K M" uniqKey="Taufiqur Rahman K" first="K M" last="Taufiqur Rahman">K M Taufiqur Rahman</name>
<affiliation>
<nlm:affiliation>Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, Ontario K1N6N5, Canada. Electronic address: krahm066@uottawa.ca.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mahedi Hasan, A M" sort="Mahedi Hasan, A M" uniqKey="Mahedi Hasan A" first="A M" last="Mahedi Hasan">A M Mahedi Hasan</name>
<affiliation>
<nlm:affiliation>Institute of Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3FF, UK. Electronic address: A.M.M.Hasan@ed.ac.uk.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Didarul Islam, K M" sort="Didarul Islam, K M" uniqKey="Didarul Islam K" first="K M" last="Didarul Islam">K M Didarul Islam</name>
<affiliation>
<nlm:affiliation>Biotechnology and Genetic Engineering Discipline, Khulna University, Khulna 9208, Bangladesh.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Taylor Robinson, Andrew W" sort="Taylor Robinson, Andrew W" uniqKey="Taylor Robinson A" first="Andrew W" last="Taylor-Robinson">Andrew W. Taylor-Robinson</name>
<affiliation>
<nlm:affiliation>School of Health, Medical & Applied Sciences, Central Queensland University, Brisbane, QLD 4000, Australia. Electronic address: a.taylor-robinson@cqu.edu.au.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Billah, Md Morsaline" sort="Billah, Md Morsaline" uniqKey="Billah M" first="Md Morsaline" last="Billah">Md Morsaline Billah</name>
<affiliation>
<nlm:affiliation>Biotechnology and Genetic Engineering Discipline, Khulna University, Khulna 9208, Bangladesh. Electronic address: morsaline@yahoo.com.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Cytokine</title>
<idno type="eISSN">1096-0023</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Disease fatality associated with Ebola, SARS-CoV and dengue infections in humans is attributed to a cytokine storm that is triggered by excessive pro-inflammatory responses. Interleukin (IL)-6 acts as a mediator between pro- and anti-inflammatory reactivity by initiating trans- and classical-signaling, respectively. Hence, IL-6 is assumed to provide a target for a broad range of antiviral agents. Available immunosuppressive antivirals are directed to control an often exaggerated pro-inflammatory response that gives rise to complex clinical conditions such as lymphocytopenia. It is known that IL-6, via its soluble receptor (sIL-6R), initiates a pro-inflammatory response while an anti-inflammatory response is triggered by the membrane-bound IL-6 receptor (IL-6R). Future antivirals should thus aim to target the mechanism that regulates switching between IL-6 trans- and classical-signaling. In this review, we propose that the tumour necrosis factor-α converting enzyme ADAM-17 could be the master molecule involved in regulating IL-6 class switching and through this in controlling pro- and anti-inflammatory responses to viral antigenic stimuli. Therefore, ADAM-17 should be considered as a potential target molecule for novel antiviral drug discovery that would regulate host reactivity to infection and thereby limit or prevent fatal outcomes.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="In-Process" Owner="NLM">
<PMID Version="1">30616034</PMID>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1096-0023</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>115</Volume>
<PubDate>
<Year>2019</Year>
<Month>03</Month>
</PubDate>
</JournalIssue>
<Title>Cytokine</Title>
<ISOAbbreviation>Cytokine</ISOAbbreviation>
</Journal>
<ArticleTitle>Decoding the enigma of antiviral crisis: Does one target molecule regulate all?</ArticleTitle>
<Pagination>
<MedlinePgn>13-23</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1043-4666(18)30483-6</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cyto.2018.12.008</ELocationID>
<Abstract>
<AbstractText>Disease fatality associated with Ebola, SARS-CoV and dengue infections in humans is attributed to a cytokine storm that is triggered by excessive pro-inflammatory responses. Interleukin (IL)-6 acts as a mediator between pro- and anti-inflammatory reactivity by initiating trans- and classical-signaling, respectively. Hence, IL-6 is assumed to provide a target for a broad range of antiviral agents. Available immunosuppressive antivirals are directed to control an often exaggerated pro-inflammatory response that gives rise to complex clinical conditions such as lymphocytopenia. It is known that IL-6, via its soluble receptor (sIL-6R), initiates a pro-inflammatory response while an anti-inflammatory response is triggered by the membrane-bound IL-6 receptor (IL-6R). Future antivirals should thus aim to target the mechanism that regulates switching between IL-6 trans- and classical-signaling. In this review, we propose that the tumour necrosis factor-α converting enzyme ADAM-17 could be the master molecule involved in regulating IL-6 class switching and through this in controlling pro- and anti-inflammatory responses to viral antigenic stimuli. Therefore, ADAM-17 should be considered as a potential target molecule for novel antiviral drug discovery that would regulate host reactivity to infection and thereby limit or prevent fatal outcomes.</AbstractText>
<CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mahmud-Al-Rafat</LastName>
<ForeName>Abdullah</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Research & Development Division, Incepta Vaccine Ltd., Zirabo, Savar, Dhaka 1341, Bangladesh; Biotechnology and Genetic Engineering Discipline, Khulna University, Khulna 9208, Bangladesh. Electronic address: mahmud0907@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Majumder</LastName>
<ForeName>Apurba</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover 30625, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taufiqur Rahman</LastName>
<ForeName>K M</ForeName>
<Initials>KM</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, Ontario K1N6N5, Canada. Electronic address: krahm066@uottawa.ca.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mahedi Hasan</LastName>
<ForeName>A M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Institute of Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3FF, UK. Electronic address: A.M.M.Hasan@ed.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Didarul Islam</LastName>
<ForeName>K M</ForeName>
<Initials>KM</Initials>
<AffiliationInfo>
<Affiliation>Biotechnology and Genetic Engineering Discipline, Khulna University, Khulna 9208, Bangladesh.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taylor-Robinson</LastName>
<ForeName>Andrew W</ForeName>
<Initials>AW</Initials>
<AffiliationInfo>
<Affiliation>School of Health, Medical & Applied Sciences, Central Queensland University, Brisbane, QLD 4000, Australia. Electronic address: a.taylor-robinson@cqu.edu.au.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Billah</LastName>
<ForeName>Md Morsaline</ForeName>
<Initials>MM</Initials>
<AffiliationInfo>
<Affiliation>Biotechnology and Genetic Engineering Discipline, Khulna University, Khulna 9208, Bangladesh. Electronic address: morsaline@yahoo.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2019</Year>
<Month>01</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Cytokine</MedlineTA>
<NlmUniqueID>9005353</NlmUniqueID>
<ISSNLinking>1043-4666</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">ADAM-17</Keyword>
<Keyword MajorTopicYN="Y">Antiviral</Keyword>
<Keyword MajorTopicYN="Y">Cytokine storm</Keyword>
<Keyword MajorTopicYN="Y">Dengue</Keyword>
<Keyword MajorTopicYN="Y">Ebola</Keyword>
<Keyword MajorTopicYN="Y">IL-6</Keyword>
<Keyword MajorTopicYN="Y">Pro-inflammatory response</Keyword>
<Keyword MajorTopicYN="Y">SARS-CoV</Keyword>
<Keyword MajorTopicYN="Y">Virus</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2018</Year>
<Month>06</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2018</Year>
<Month>12</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2018</Year>
<Month>12</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>1</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>1</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>1</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">30616034</ArticleId>
<ArticleId IdType="pii">S1043-4666(18)30483-6</ArticleId>
<ArticleId IdType="doi">10.1016/j.cyto.2018.12.008</ArticleId>
<ArticleId IdType="pmc">PMC7129598</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Viruses. 2012 Nov 01;4(11):2736-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23202502</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cell Host Microbe. 2016 Feb 10;19(2):139-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26867172</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1977-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12671062</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Negl Trop Dis. 2017 Feb 23;11(2):e0005389</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28231247</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>JAMA. 2003 Dec 24;290(24):3222-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14693875</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Immunol. 2003 Sep 15;171(6):3202-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12960349</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Hong Kong Med J. 2003 Dec;9(6):399-406</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14660806</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mem Inst Oswaldo Cruz. 2009 Dec;104(8):1091-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20140369</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Int J Antimicrob Agents. 2014 Dec;44(6):528-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25288266</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>JAMA. 2003 Jun 4;289(21):2801-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12734147</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Int J Biol Sci. 2012;8(9):1237-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23136552</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cell. 2014 Oct 23;159(3):477-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25417101</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>F1000Res. 2016 Jan 19;5:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26918159</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Immunology. 2017 Jul;151(3):261-269</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28437586</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2016 Dec 22;11(12):e0168973</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28006034</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Adv Enzyme Regul. 1995;35:293-301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7572350</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>FASEB J. 2001 Jan;15(1):43-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11149892</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Biol Chem. 2015 Nov 6;290(45):26943-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26363066</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2006 Feb 16;354(7):697-708</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16481637</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antimicrob Agents Chemother. 2005 Mar;49(3):981-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15728892</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Virol. 2005 Feb;75(2):185-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15602737</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Neurochem. 2002 Dec;83(6):1349-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12472889</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Dis Markers. 2018 Jan 30;2018:8403937</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29651328</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Exp Med. 1989 Jan 1;169(1):333-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2783334</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Viruses. 2014 Dec;6(12):4880-901</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25494448</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biochim Biophys Acta. 2011 May;1813(5):878-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21296109</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Immunol. 2012 Sep 15;189(6):3130-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22896632</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2014 Apr;104:153-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24462697</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Curr Pharm Des. 2009;15(20):2319-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19601834</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Immunol. 2000 Dec;1(6):510-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11101873</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):4719-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25775592</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Aliment Pharmacol Ther. 2001 Oct;15(10):1515-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11563990</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Biol Chem. 2011 Nov 11;286(45):38980-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21949123</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2015 Feb 13;347(6223):701-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25678637</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25352553</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Interferon Cytokine Res. 2009 Sep;29(9):511-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19694547</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Negl Trop Dis. 2010 Aug 10;4(8):e785</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20706626</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Arthritis Rheum. 2010 Nov;62(11):3477-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20583103</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Infect Dis. 2016 Feb 15;62(4):468-476</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26565005</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1986-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12682352</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12781535</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMC Genomics. 2016 Sep 05;17:707</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27595844</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virus Res. 2008 Apr;133(1):101-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17451827</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Semin Immunopathol. 2017 Jul;39(5):563-574</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28401256</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Eur Cytokine Netw. 2000 Sep;11(3):443-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11022130</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Exp Med. 2005 Aug 1;202(3):415-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16043521</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mediators Inflamm. 2017;2017:9673537</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29230082</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>EMBO Rep. 2006 Nov;7(11):1176-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17028575</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Blood. 2007 Sep 15;110(6):1748-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17567983</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Blood. 2003 Aug 15;102(4):1186-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12714508</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Immunity. 2012 Jan 27;36(1):105-19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22284418</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Biol Chem. 1998 Mar 27;273(13):7620-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9516466</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Kidney Int. 2005 Apr;67(4):1216-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15780075</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Atherosclerosis. 2013 May;228(1):12-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23384719</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Thorax. 2004 Mar;59(3):252-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14985565</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S53-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19932918</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Protein Sci. 1997 May;6(5):929-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9144766</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Exp Clin Cancer Res. 2013 May 09;32:26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23659326</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Immunol. 2009 Apr;46(7):1443-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19181387</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Pathol. 2008 Jan;214(2):149-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18161752</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Indian J Clin Biochem. 2005 Jul;20(2):92-103</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23105540</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Exp Immunol. 2006 Feb;143(2):345-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16412060</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Physiol Gastrointest Liver Physiol. 2013 Jul 1;305(1):G25-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23639813</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2017 Jan 15;215(2):287-292</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27799354</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Pathog. 2018 Apr 12;14(4):e1006932</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29649305</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1995-2005</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12671061</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMC Infect Dis. 2013 Jul 24;13:341</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23883139</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>FASEB J. 2006 Oct;20(12):2174-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16912152</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Viruses. 2012 Jan;4(1):62-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22355452</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cell Death Differ. 2015 Aug;22(8):1250-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26024394</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Int J Biochem Cell Biol. 2005 Aug;37(8):1560-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15896665</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Biochem Rev. 2004 May;25(2):121-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18458712</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Zoonoses Public Health. 2013 Feb;60(1):104-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23302292</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Viruses. 2015 Oct 23;7(10):5489-507</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26512687</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Eur J Immunol. 2002 Oct;32(10):2965-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12355450</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Immunol. 2008 Oct 15;181(8):5490-500</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18832706</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nucleic Acids Res. 2010 Jul;38(Web Server issue):W214-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20576703</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Microbiol. 2003 Aug;52(Pt 8):715-720</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12867568</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2012;7(10):e45027</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23049677</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Genome Res. 2003 Nov;13(11):2498-504</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14597658</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Crit Care Med. 2011 Jun;39(6):1407-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21336117</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Intervirology. 2011;54(4):202-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21293097</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Drug Discov. 2004 Jan;3(1):17-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14708018</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Eur J Immunol. 2008 Jan;38(1):174-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18085664</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Eur J Immunol. 2006 Apr;36(4):968-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16541467</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2011 Mar 5;377(9768):849-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21084112</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Pathog. 2014 Dec 04;10(12):e1004541</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25474197</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Neuroimmunol. 1999 Oct 29;99(2):218-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10505978</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Semin Immunopathol. 2017 Jul;39(5):517-528</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28555385</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trends Cell Biol. 2012 Nov;22(11):557-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22995730</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMC Infect Dis. 2011 Apr 21;11:106</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21510901</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Immunol. 1992 Apr 1;148(7):2175-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1545125</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Eur J Biochem. 2004 Jul;271(13):2808-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15206946</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Annu Rev Pathol. 2017 Jan 24;12:387-418</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27959626</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cell Mol Immunol. 2012 Mar;9(2):155-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21983868</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cardiovasc Res. 2010 May 1;86(2):211-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20202975</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2006 Mar;80(6):3009-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16501110</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2002 Dec 15;186(12):1790-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12447765</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Cell Biol. 2009 Nov;29(21):5679-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19704010</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Immunol. 2015 May;16(5):448-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25898198</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Immunity. 2008 Nov 14;29(5):691-703</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18976936</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Int J Cancer. 1994 May 1;57(3):318-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8168990</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sci China Life Sci. 2015 Jan;58(1):111-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25558864</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Microbiol Mol Biol Rev. 2012 Mar;76(1):16-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22390970</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Microbiol Rev. 2009 Oct;22(4):564-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19822889</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Invest. 2005 Feb;115(2):313-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15668741</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Negl Trop Dis. 2010 Oct 05;4(10):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20957152</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Autoimmun. 2014 Dec;55:1-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25260583</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Pathol. 2013 Jun;182(6):1950-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23567637</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Front Microbiol. 2013 Oct 11;4:305</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24130557</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Immunol. 2010 Jan 1;184(1):327-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20028660</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Microbiol Immunol. 2014 Jun;58(6):318-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24773578</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Infect Dis. 2014 Aug;14(8):706-715</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24877997</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2007 Nov 15;196 Suppl 2:S357-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17940971</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Immunol. 2007 Aug 15;179(4):2041-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17675459</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Am Soc Nephrol. 2015 Nov;26(11):2860-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25788529</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Aliment Pharmacol Ther. 2006 Jul 15;24(2):319-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16842459</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virol Sin. 2015 Oct;30(5):326-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26494479</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Infect Dis. 2013 Mar;56(6):901-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23243185</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Immunology. 2004 Dec;113(4):427-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15554920</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Cell Biol. 1990 May;10(5):2327-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2183031</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trends Immunol. 2011 Aug;32(8):380-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21752713</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Front Biosci (Landmark Ed). 2018 Jan 1;23:947-953</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28930583</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2002 Oct 15;186(8):1165-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12355369</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Themes Epidemiol. 2005 Mar 02;2(1):1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15743532</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Oncogene. 2013 Oct 10;32(41):4892-902</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23178494</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMJ. 2003 Sep 13;327(7415):620</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12969939</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Infect Ecol Epidemiol. 2013 Aug 30;3:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24003364</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Bioorg Med Chem Lett. 2002 May 20;12(10):1387-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11992783</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Curr Opin Investig Drugs. 2006 Nov;7(11):1014-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17117591</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2009 May;82(2):A84-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19425198</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2013 May 1;207(9):1442-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22807519</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2013 Jul;87(13):7471-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23616668</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2014 Apr 15;9(4):e83386</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24736395</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>mBio. 2013 Aug 06;4(4):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23919993</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2010 Feb;84(3):1289-301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19906920</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2003 May 24;361(9371):1761-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12781533</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):281-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22075248</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2014 Feb 21;9(2):e87412</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24586275</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2012 Jan 20;422(2):326-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22129847</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biochem J. 2003 Aug 15;374(Pt 1):1-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12773095</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2011 Oct 20;365(16):1502-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22010916</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Dis Model Mech. 2009 Jan-Feb;2(1-2):12-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19132113</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2003 Jun;9(6):713-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12781012</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2003 Jun 7;361(9373):1985</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12801759</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2005 Sep;79(17):11053-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16103156</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2002 Nov 14;420(6912):206-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12432404</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2003 May 10;361(9369):1615-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12747883</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2016 May 5;533(7601):100-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27147028</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Infect Drug Resist. 2014 May 22;7:137-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24899817</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sci Rep. 2015 May 21;5:10501</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25994622</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Bioorg Med Chem Lett. 2001 Jan 22;11(2):239-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11206468</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Crit Rev Biochem Mol Biol. 2010 Apr;45(2):146-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20184396</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E433-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12857678</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000941 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000941 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:30616034
   |texte=   Decoding the enigma of antiviral crisis: Does one target molecule regulate all?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:30616034" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021